Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Trina Krug on MSN3h
What If You Want a GLP-1 Alternative That’s More Natural?There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...
Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback